Thu, February 27, 2020

Alethia Young Reiterated (SRPT) at Buy with Increased Target to $217 on, Feb 27th, 2020

Alethia Young of Cantor Fitzgerald, Reiterated "Sarepta Therapeutics, Inc." (SRPT) at Buy with Increased Target from $211 to $217 on, Feb 27th, 2020.

Alethia has made no other calls on SRPT in the last 4 months.



There are 6 other peers that have a rating on SRPT. Out of the 6 peers that are also analyzing SRPT, 0 agree with Alethia's Rating of Hold.



These are the ratings of the 6 analyists that currently disagree with Alethia


  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $173 on, Tuesday, December 24th, 2019
  • Brian Abrahams of "RBC Capital" Maintained at Buy with Decreased Target to $200 on, Monday, December 23rd, 2019
  • Brian Skorney of "Baird" Maintained at Buy with Increased Target to $192 on, Friday, December 20th, 2019
  • Yun Zhong of "Janney Montgomery Scott" Maintained at Strong Buy with Increased Target to $175 on, Friday, December 13th, 2019
  • Joel Beatty of "Citigroup" Maintained at Strong Buy with Decreased Target to $167 on, Monday, November 18th, 2019
  • Whitney Ijem of "Guggenheim" Initiated at Strong Buy and Held Target at $183 on, Friday, November 1st, 2019